Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant pleural effusions.

M A Friedman, E Slater

    Cancer Treatment Reviews
    |June 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Recurrent malignant pleural effusion management requires aggressive treatment for palliation and survival. Treatment plans must consider effusion causes, cancer type, patient status, and pleural conditions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management.

    Contemporary clinical trials·2018
    Same author

    Psychiatric genetics.

    Recent progress in psychiatry·2014
    Same author

    Pharmacokinetics of acrylamide after oral administration in male rats.

    Environmental toxicology and pharmacology·2011
    Same author

    A HEURISTIC THEORY OF NEUROSIS.

    Journal of neurology and psychiatry·2011
    Same author

    NEUROSIS AND SEXUALITY.

    Journal of neurology, neurosurgery, and psychiatry·2011
    Same author

    THE NEUROTIC CONSTITUTION: A Statistical Study of Two Thousand Neurotic Soldiers.

    Journal of neurology and psychiatry·2011
    Same journal

    Antiangiogenic therapies in gastric cancer: future directions for 2026 and beyond: an UNICANCER gastrointestinal group (UCGI) perspective.

    Cancer treatment reviews·2026
    Same journal

    Treatment of breast cancer brain metastases in the era of novel drugs.

    Cancer treatment reviews·2026
    Same journal

    Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck.

    Cancer treatment reviews·2026
    Same journal

    Precision targeting of CLDN18.2: A new therapeutic paradigm for gastric cancer.

    Cancer treatment reviews·2026
    Same journal

    Beyond body surface area: CT-derived body composition as a predictor of chemotherapy toxicity and survival in pancreatic ductal adenocarcinoma: a systematic review.

    Cancer treatment reviews·2026
    Same journal

    Early onset pancreatic Cancer: epidemiology, molecular features, and clinical outcomes.

    Cancer treatment reviews·2026
    See all related articles

    Area of Science:

    • Pulmonology
    • Oncology

    Background:

    • Recurrent malignant pleural effusion is a frequent complication preceding terminal cancer stages.
    • Identifying the precise cause and optimal therapy for these effusions can be challenging.

    Purpose of the Study:

    • To outline a comprehensive approach for managing recurrent malignant pleural effusion.
    • To emphasize aggressive palliative and potentially survival-extending treatment strategies.

    Main Methods:

    • Review of pathogenic mechanisms and therapeutic options for malignant pleural effusion.
    • Consideration of factors influencing treatment decisions, including cancer type and patient condition.

    Main Results:

    • Aggressive management, including chest tube drainage, intrapleural therapies, radiotherapy, or surgery, is recommended.

    Related Experiment Videos

  • Careful evaluation of effusion etiology, malignancy characteristics, and pleural abnormalities is crucial.

    • Conclusions:

    • Effective management of malignant pleural effusion necessitates an aggressive, individualized treatment strategy.
    • Addressing pathogenic factors and patient-specific variables is key to successful outcomes.